.
"we were fully aware of the fact that our twins would be the first babies in the world to receive this treatment in utero," corinna said.
.
despite neutral imaging results, adalimumab did improve other key markers of inflammation in the blood including glyca, crp, tnf, and il-6.
.
.
.
.